High Prevalence of Hereditary Cancer Syndromes in Adolescents and Young Adults With Colorectal Cancer.

PURPOSE Established guidelines recommend evaluation for hereditary cancer syndromes in patients younger than 50 years diagnosed with colorectal cancer (CRC). This group has been well described in the literature; however, patients diagnosed as adolescents and young adults are not well represented in CRC studies. Here, we define the clinical profile, including the extent of hereditary cancer syndromes and family history of cancer, in patients diagnosed with CRC at age 35 or younger. PATIENTS AND METHODS We reviewed patients who underwent genetic counseling at our institution during 5 years (2009 to 2013). Data were collected regarding demographics, clinicopathologic information, tumor and genetic testing, and family history. Patients with an identified hereditary cancer syndrome were compared with those without a syndrome. RESULTS Of the 193 patients with evaluable data, 35% had an identifiable hereditary cancer syndrome, including 23 with Lynch syndrome, 22 with mutation-negative Lynch syndrome, 16 with familial adenomatous polyposis, two with constitutional mismatch repair deficiency, two with biallelic MUTYH mutations, and one with Li-Fraumeni syndrome. Patients without a hereditary syndrome more frequently presented with metastatic disease, whereas patients with a syndrome were more likely to present at earlier stages and to have a family history of cancer. Nevertheless, a substantial proportion of the hereditary syndromes (19%) were diagnosed in individuals with no family history of the disease. CONCLUSION We conclude that patients diagnosed with CRC at age 35 years or younger should receive genetic counseling regardless of their family history and phenotype.

[1]  S. Cantor,et al.  Increasing disparities in the age-related incidences of colon and rectal cancers in the United States, 1975-2010. , 2015, JAMA surgery.

[2]  J. Potter,et al.  Lower cancer incidence in Amsterdam-I criteria families without mismatch repair deficiency: familial colorectal cancer type X. , 2005, JAMA.

[3]  D. Malkin,et al.  High frequency of de novo mutations in Li–Fraumeni syndrome , 2009, Journal of Medical Genetics.

[4]  T. Tuohy,et al.  Hereditary and familial colon cancer. , 2010, Gastroenterology.

[5]  M. Bisgaard,et al.  Familial adenomatous polyposis (FAP): Frequency, penetrance, and mutation rate , 1994, Human mutation.

[6]  R. Pai,et al.  Clinicopathologic and molecular features of sporadic early-onset colorectal adenocarcinoma: an adenocarcinoma with frequent signet ring cell differentiation, rectal and sigmoid involvement, and adverse morphologic features , 2012, Modern Pathology.

[7]  J. Potter,et al.  Eating patterns and risk of colon cancer. , 1998, American journal of epidemiology.

[8]  A. Martayan,et al.  Early-onset colorectal cancer: a sporadic or inherited disease? , 2014, World journal of gastroenterology.

[9]  E. Vilar,et al.  Classifying MMR Variants: Time for Revised Nomenclature in Lynch Syndrome , 2013, Clinical Cancer Research.

[10]  A. Grothey,et al.  Adolescent and young adult colorectal cancer. , 2013, Journal of the National Comprehensive Cancer Network : JNCCN.

[11]  A. Jemal,et al.  Cancer statistics, 2014 , 2014, CA: a cancer journal for clinicians.

[12]  H. Vasen Clinical diagnosis and management of hereditary colorectal cancer syndromes. , 2000, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[13]  Sudhir Srivastava,et al.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.

[14]  N. Petrelli,et al.  Colorectal cancer in patients aged 30 years or younger. , 1996, Surgical oncology.